Headline
The latest stories from AHA Today.
The Food and Drug Administration has identified a nationwide recall.
The AHA Leadership Summit will be held July 12-14 in Denver.
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to discounted drug prices unless they comply with new data submission requirements.
The Utah measles outbreak has increased to 607 cases, the state’s Department of Health and Human Services reported April 24.
The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent. This is the 17th such agreement by a drug manufacturer with the Trump administration, and it ensures Regeneron’s prices are in line with the lowest…
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18 executive order calling to speed up access to treatments for serious mental illness.
The AHA April 24 urged the Sequoia Project to delay implementation of the Trusted Exchange Framework and Common Agreement Individual Access Services Exchange Purpose Standard Operating Procedures version 3.0 until key legal and regulatory issues are resolved.
A joint advisory released April 23 from U.S. and international cybersecurity agencies, including the Cybersecurity and Infrastructure Security Agency, FBI, National Security Agency and other global partners, warns that China-nexus cyber actors have significantly shifted their tactics, now posing…
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-designated Class II and Class III devices for Medicare beneficiaries.
The AHA April 23 released a blog responding to a report issued April 22 by Paragon Health Institute. The blog highlights how the report relies on a long list of distorted and debunked arguments.